Enphase Energy Inc | - | 3.28% | - | - | 8,430 |
Align Technology Inc | - | 2.67% | - | - | 1,597 |
Bristol-Myers Squibb Co | - | 2.64% | - | - | 4,862 |
Merck & Co Inc | - | 2.63% | - | - | 2,423 |
Cirrus Logic Inc | - | 2.63% | - | - | 2,028 |
F5 Inc | - | 2.53% | - | - | 1,030 |
Regeneron Pharmaceuticals Inc | - | 2.46% | - | - | 342 |
Teradata Corp | - | 2.45% | - | - | 8,160 |
BioMarin Pharmaceutical Inc | - | 2.45% | - | - | 4,562 |
Biogen Inc | - | 2.41% | - | - | 1,369 |
The Alger ETF Trust - Alger Russell Innovation ETF is an exchange traded fund launched and managed by Fred Alger Management, LLC. It invests in public equity markets of the United States. It invests in stocks of companies operating across diversified sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the Alger Russell Innovation Index, by using full replication technique. The Alger ETF Trust - Alger Russell Innovation ETF was formed on January 6, 2025, and is domiciled in the United States.